NCT01825733View on ClinicalTrials.gov

Comparison of Palonosetron and Ramosetron for Preventing Patient-controlled Analgesia Related Nausea and Vomiting Following Spine Surgery

NACompletedINTERVENTIONAL
Enrollment

196

Participants

Timeline

Start Date

August 31, 2011

Primary Completion Date

July 31, 2012

Study Completion Date

July 31, 2012

Conditions
Postoperative Nausea and Vomiting
Interventions
DRUG

ramosetron

Ramosetron 0.3 mg was mixed to the PCA. Same dose of drug was administered 10 minutes before the end of surgery according to the allocated group.

DRUG

palonosetron

palonosetrno 0.075 mg was mixed to the PCA. Same dose of drug was administered 10 minutes before the end of surgery according to the allocated group.

All Listed Sponsors
lead

Yonsei University

OTHER

NCT01825733 - Comparison of Palonosetron and Ramosetron for Preventing Patient-controlled Analgesia Related Nausea and Vomiting Following Spine Surgery | Biotech Hunter | Biotech Hunter